OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Associations Between Using Chinese Herbal Medicine and Long-Term Outcome Among Pre-dialysis Diabetic Nephropathy Patients: A Retrospective Population-Based Cohort Study
Jenny Chun-Ling Guo, Heng‐Chih Pan, Bo-Yan Yeh, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 24
Jenny Chun-Ling Guo, Heng‐Chih Pan, Bo-Yan Yeh, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 24
Showing 24 citing articles:
Sodium-Glucose Cotransport Protein 2 Inhibitors in Patients With Type 2 Diabetes and Acute Kidney Disease
Heng‐Chih Pan, Jui-Yi Chen, Hsing‐Yu Chen, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2350050-e2350050
Open Access | Times Cited: 21
Heng‐Chih Pan, Jui-Yi Chen, Hsing‐Yu Chen, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2350050-e2350050
Open Access | Times Cited: 21
The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics
Vivek Kumar, Ashok Kumar Yadav, Jasmine Sethi, et al.
Clinical Kidney Journal (2021) Vol. 15, Iss. 1, pp. 60-69
Open Access | Times Cited: 56
Vivek Kumar, Ashok Kumar Yadav, Jasmine Sethi, et al.
Clinical Kidney Journal (2021) Vol. 15, Iss. 1, pp. 60-69
Open Access | Times Cited: 56
GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease
Heng‐Chih Pan, Jui‐Yi Chen, Hsing‐Yu Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Heng‐Chih Pan, Jui‐Yi Chen, Hsing‐Yu Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Simultaneous Determination of Stilbenes, Flavones, Coumestans, Anthraquinones, and Chalcones in Ethanolic Extract of Pet-Sang-Kard Mixed Herbal Remedy Using HPLC-PDA Analysis
Weerasak Samee, Wanna Eiamart, Sarin Tadtong, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 222-222
Open Access
Weerasak Samee, Wanna Eiamart, Sarin Tadtong, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 222-222
Open Access
Renal and survival benefits of seventeen prescribed Chinese herbal medicines against oxidative-inflammatory stress in systemic lupus erythematosus patients with chronic kidney disease: a real-world longitudinal study
Hsiao-Tien Chen, Chien‐Hsueh Tung, Ben‐Hui Yu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 3
Hsiao-Tien Chen, Chien‐Hsueh Tung, Ben‐Hui Yu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 3
The Multi-Therapeutic Role of MSCs in Diabetic Nephropathy
Yi Wang, Su‐Kang Shan, Bei Guo, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 27
Yi Wang, Su‐Kang Shan, Bei Guo, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 27
Dose- and time-dependent renoprotection of Angelica sinensis in patients with chronic kidney disease: A longitudinal cohort study
Hsiao-Tien Chen, Ben‐Hui Yu, Ming-Hsien Yeh, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Hsiao-Tien Chen, Ben‐Hui Yu, Ming-Hsien Yeh, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists
Hsuan-Wen Lai, Chun Yin See, Jui‐Yi Chen, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Hsuan-Wen Lai, Chun Yin See, Jui‐Yi Chen, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Four prescribed Chinese herbal medicines provide renoprotection and survival benefit without hyperkalemia risk in patients with advanced chronic kidney disease: A nationwide cohort study
Yi‐Chun Chen, Hsiao-Tien Chen, Chia-Chou Yeh, et al.
Phytomedicine (2021) Vol. 95, pp. 153873-153873
Open Access | Times Cited: 21
Yi‐Chun Chen, Hsiao-Tien Chen, Chia-Chou Yeh, et al.
Phytomedicine (2021) Vol. 95, pp. 153873-153873
Open Access | Times Cited: 21
Effectiveness of Integrative Chinese–Western Medicine for Chronic Kidney Disease and Diabetes: A Retrospective Cohort Study
Kam Wa Chan, Tak Yee Chow, Kam Yan Yu, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 02, pp. 371-388
Closed Access | Times Cited: 14
Kam Wa Chan, Tak Yee Chow, Kam Yan Yu, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 02, pp. 371-388
Closed Access | Times Cited: 14
Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis
Kam Wa Chan, Kam Yan Yu, Wai Han Yiu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Kam Wa Chan, Kam Yan Yu, Wai Han Yiu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy
Borui Yu, Mengqi Zhou, Zhaocheng Dong, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1222-1233
Open Access | Times Cited: 6
Borui Yu, Mengqi Zhou, Zhaocheng Dong, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1222-1233
Open Access | Times Cited: 6
Effect and pharmacological mechanism of Salvia miltiorrhiza and its characteristic extracts on diabetic nephropathy
Lu-Qi Cai, Yu Chen, Huizhong Xue, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117354-117354
Closed Access | Times Cited: 5
Lu-Qi Cai, Yu Chen, Huizhong Xue, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117354-117354
Closed Access | Times Cited: 5
Radix Astragali and Its Representative Extracts for Diabetic Nephropathy: Efficacy and Molecular Mechanism
Hui‐zhong Xue, Yu Chen, Shi-Dong Wang, et al.
Journal of Diabetes Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Hui‐zhong Xue, Yu Chen, Shi-Dong Wang, et al.
Journal of Diabetes Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Gambogenic acid protects against high glucose-induced damage of renal tubular epithelial cells by inhibiting pyroptosis through regulating the AMPK–TXNIP pathway
Ningxu Li, Xiuying Wen, Mingjuan Tang, et al.
Quality Assurance and Safety of Crops & Foods (2022) Vol. 14, Iss. 2, pp. 40-46
Open Access | Times Cited: 7
Ningxu Li, Xiuying Wen, Mingjuan Tang, et al.
Quality Assurance and Safety of Crops & Foods (2022) Vol. 14, Iss. 2, pp. 40-46
Open Access | Times Cited: 7
The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation
Yanzhe Wang, Yuyuan Liu, Sijia Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Yanzhe Wang, Yuyuan Liu, Sijia Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Application of Metabolomics and Traditional Chinese Medicine for Type 2 Diabetes Mellitus Treatment
Jing Li, Na Zhu, Yaqiong Wang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 4269-4282
Open Access | Times Cited: 2
Jing Li, Na Zhu, Yaqiong Wang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 4269-4282
Open Access | Times Cited: 2
Traditional Chinese medicine for the treatment of diabetic kidney disease: A study-level pooled analysis of 44 randomized controlled trials
Xuele Liu, Minyao Ge, Xinyu Zhai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Xuele Liu, Minyao Ge, Xinyu Zhai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Uma prática integrativa para o tratamento de depressão: Uma Revisão Sistemática
Carlos Henrique Pinto Missioneiro, Hosana De Araújo Almeida, Mariana Machado Lima
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 4, pp. 1259-1286
Open Access
Carlos Henrique Pinto Missioneiro, Hosana De Araújo Almeida, Mariana Machado Lima
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 4, pp. 1259-1286
Open Access
Can Chinese herbal medicine offer feasible solutions for newly diagnosed esophageal cancer patients with malnutrition? a multi-institutional real-world study
Yi-Chin Lu, Liang-Wei Tseng, Chiao‐En Wu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Yi-Chin Lu, Liang-Wei Tseng, Chiao‐En Wu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Sixteen prescribed Chinese herbal medicines provide time-dependent cardiorenal and survival benefits in patients with overall and advanced diabetic kidney disease: a real-world study in Taiwan
Hsiao-Tien Chen, Chien‐Hsueh Tung, Ben‐Hui Yu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Hsiao-Tien Chen, Chien‐Hsueh Tung, Ben‐Hui Yu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
The association between mortality and use of Chinese herbal medicine among incident stage IV esophageal cancer patients: A retrospective cohort study with core herbs exploration
Shuling Chen, Wei-Chun Lin, Yu‐Chun Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Shuling Chen, Wei-Chun Lin, Yu‐Chun Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Jian-Pi-Yi-Shen formula alleviates renal fibrosis by restoring NAD+ biosynthesis in vivo and in vitro
Liwen Gao, Xi Huang, Ruyu Deng, et al.
Aging (2023)
Open Access | Times Cited: 1
Liwen Gao, Xi Huang, Ruyu Deng, et al.
Aging (2023)
Open Access | Times Cited: 1
A deep clustering-based mass spectral data visualization strategy for anti-renal fibrotic lead compound identification from natural products
Jieying Lai, Lichuang Huang, Yini Bao, et al.
The Analyst (2022) Vol. 147, Iss. 21, pp. 4739-4751
Closed Access | Times Cited: 2
Jieying Lai, Lichuang Huang, Yini Bao, et al.
The Analyst (2022) Vol. 147, Iss. 21, pp. 4739-4751
Closed Access | Times Cited: 2
